Navigation Links
Weikang Bio-Technology Announces Fiscal 2010 Financial Results
Date:3/22/2011

80,019Account receivable652,167-Advances to suppliers and other receivables241,34226,079Inventory388,535285,395Deferred compensation902,226-Total current assets52,548,08211,691,493NONCURRENT ASSETSDeferred compensation-noncurrent16,077-Property and equipment, net9,606,26910,162,946Construction in progress683,830-Intangible assets15,754,66615,558,731Total noncurrent assets26,060,84225,721,677TOTAL ASSETS$
78,608,924$
37,413,170LIABILITIES AND STOCKHOLDERS' EQUITYCURRENT LIABILITIESAccounts payable$
4,204$
2,668Unearned revenue528,48511,716Taxes payable6,269,4222,247,410Accrued expenses1,376,154-Due to related party25,669-Total current liabilities8,213,9342,271,794ADVANCE FROM OFFICER-650,000OTHER LIABILITY-7,620,321CONTINGENCIES DEFERRED TAX LIABILITY3,464,8153,450,005STOCKHOLDERS' EQUITYCommon stock,  $.00001 par value;  authorized shares ,000,000;  issued and outstanding shares 29,963,551 and 25,486,800 at December 31, 2010 and 2009, respectively

300255Additional paid in capital17,530,601139,245Statutory reserve2,431,9271,069,507Accumulated other comprehensive income2,524,566844,526Retained earnings 44,442,78121,367,517Total stockholders' equity 66,930,17523,421,050TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$
78,608,924$
37,413,170WEIKANG BIO-TECHNOLOGY GROUP CO, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWS YEARS
 ENDED DECEMBER 31,20102009CASH FLOWS FROM OPERATING ACTIVITIES:Net income $
24,437,684$
5,616,802Adjustments to reconcile net income to net cashprovided by operating activities:Depreciation and amortization1,193,0451,176,909Stock compensation 3,843,732139,500Stock option35,132-Changes in deferred tax(90,241)(104,306)(Increase) decrease in current assets:Accounts receivable(638,024)-Advances to suppliers and other receivables(214,767)(1,903)Inventory (92,239)(133,257)Increase (decrease) in current liabilities:Accounts pay
'/>"/>

SOURCE Weikang Bio-Technology Group Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Weikang Bio-Technology Issues 2010 and 2011 Fiscal Year Guidance
2. Weikang Bio-Technology to Present at Rodman and Renshaws Annual Global Investment Conference on September 14th 2010
3. Weikang Bio-Technology Reports Second Quarter 2010 Financial Results
4. ICAP Ocean Tomo Announces the Auction of an Improved Compact, Portable Nebulizer Developed and Patented by Tidal Air
5. American Oriental Bioengineering Announces US$20 Million Share Repurchase Program
6. Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication
7. Cord Blood America Announces Affiliate Program to Educate on Value of Umbilical Cord Blood Stem Cell Storage
8. Cytokinetics announces fundamental research in cardiac myosin activation in the journal Science
9. Genesis Biopharma Announces Plans to Develop Active Immunotherapy Platform
10. Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA
11. Seattle BioMed Announces Major Scientific Expansion, New Addition to Leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Platelets, the tiny cell fragments whose job it is ... a cell nucleus. But they can "feel" the physical ... have discovered. , Platelets respond to surfaces with greater ... they "turn on" other platelets and other components of ... smarter than we give them credit for, in that ...
(Date:9/22/2014)... a way to create a highly sensitive chemical sensor ... imperfections have unique electronic properties that the researchers were ... molecules by 300 times. , The study is available ... . , Amin Salehi- Khojin, asst professor of mechanical ... graduate student and Bijandra Kumar, post doc where they ...
(Date:9/22/2014)... Topical BioMedics, Inc., is celebrating 20 years ... suffering, restoring hope an quality of life and contributing ... because of the innovative cellular biomedicines research that made ... , The company was founded in 1994 in ... chief of research, and Topricin inventor), Aurora Paradise (COO) ...
(Date:9/22/2014)... 2014 Invisible Sentinel Inc., a ... food and beverage industries, announced today that its ... a non-exclusive agreement by Enartis, a global provider ... an Esseco Group company headquartered in Trecate, Italy, ... and other global markets for their own in-winery ...
Breaking Biology Technology:Platelets modulate clotting behavior by 'feeling' their surroundings 2Graphene imperfections key to creating hypersensitive 'electronic nose' 2Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 2Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 3Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 4Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 5Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 6Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally 2Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally 3
... Matrox Graphics Inc., the leading,manufacturer of specialized ... Matrox Xenia(TM) Series display controller boards with its,ME/CCL ... first native PCI Express single-slot board with,all-digital, triple-monitor ... configuration. Xenia Series supports resolutions from <1MP to,8MP ...
... Pressure,BioSciences, Inc. (Nasdaq: PBIO ) ("PBI") today ... presentation of favorable data,generated by scientists at Amgen, ... scheduled presentation by Dr. Paul Pevsner of the,NYU ... in identifying potential protein,biomarkers in colon cancer samples, ...
... 8 Transcept Pharmaceuticals,Inc., a privately-held specialty pharmaceutical ... President and Chief Financial Officer,is scheduled to present ... in New York City on Monday, October 13, ... webcast of the presentation will be available at, ...
Cached Biology Technology:Totoku Europe Chooses Matrox Xenia(TM) Series to Drive Medical Monitors 2Pressure BioSciences, Inc. Provides Corporate Update 2Pressure BioSciences, Inc. Provides Corporate Update 3Pressure BioSciences, Inc. Provides Corporate Update 4Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference 2
(Date:9/22/2014)... Yale University researchers are studying a potential new treatment ... disease in which scars develop in the lungs and ... mimic, miR-29, which is delivered to lung tissue intravenously. ... it reversed fibrosis after several days. , The ... EMBO Molecular Medicine . , "The mimic, when injected ...
(Date:9/22/2014)... Rochelle, NY, September 22, 2014Cassava, also known as tapioca, ... yields in areas of Africa, Asia, and Latin America ... the availability of novel enzymes and processes designed to ... be used to produce sweeteners such as glucose, fructose, ... to corn, as described in a Review article in ...
(Date:9/22/2014)... Antarctic fishes that manufacture their own "antifreeze" ... also suffer an unfortunate side effect, researchers report: ... bodies resist melting even when temperatures warm. ... Proceedings of the National Academy of Sciences . ... undesirable consequence of the evolution of antifreeze proteins ...
Breaking Biology News(10 mins):Reversing the effects of pulmonary fibrosis 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 3
... single dose of gene-virus combination cured rats of a ... causes the accumulation of bilirubin –which, untreated, results in ... of Medicine in a report in the Proceedings of ... first time this disease (Crigler-Najjar syndrome) has been completely ...
... new approach to predict whether a drug in development ... could get antibiotics to market faster and more cheaply, ... scientists worldwide have sounded the alarm: There simply aren’t ... adept at outwitting the traditional antibiotic arsenal. , Yet ...
... variation that may increase susceptibility to osteoporosis, a new study ... Louis demonstrated that in women the variant gene speeds up ... in the bones of the hip. , The study will ... Bone and Mineral Research and is available online. , ...
Cached Biology News:Gene Therapy Cures Inherited Liver Disease In Rats 2New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal 2New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal 3New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal 4Increased risk of osteoporosis associated with gene that one in five people have 2
...
Ras-related C3 botulinum toxin substrate 1...
Human sVCAM-1/CD106 ELI-PAIR Kit...
HP 1 alpha Immunogen: Synthetic peptide between amino acids 1-100 of the human HP 1 alpha protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: